Caisse DE Depot ET Placement DU Quebec decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,441 shares of the medical equipment provider’s stock after selling 566 shares during the period. Caisse DE Depot ET Placement DU Quebec’s holdings in Intuitive Surgical were worth $891,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. ETRADE Capital Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth $233,000. MML Investors Services LLC lifted its position in Intuitive Surgical by 322.3% during the 4th quarter. MML Investors Services LLC now owns 2,939 shares of the medical equipment provider’s stock worth $1,073,000 after acquiring an additional 2,243 shares during the last quarter. Amundi Pioneer Asset Management Inc. acquired a new position in Intuitive Surgical during the 4th quarter worth $18,836,000. AXA lifted its position in Intuitive Surgical by 271.9% during the 4th quarter. AXA now owns 270,985 shares of the medical equipment provider’s stock worth $98,893,000 after acquiring an additional 198,125 shares during the last quarter. Finally, Douglass Winthrop Advisors LLC lifted its position in Intuitive Surgical by 200.0% during the 4th quarter. Douglass Winthrop Advisors LLC now owns 1,500 shares of the medical equipment provider’s stock worth $547,000 after acquiring an additional 1,000 shares during the last quarter. 87.85% of the stock is owned by hedge funds and other institutional investors.
In related news, Director Lonnie M. Smith sold 18,000 shares of the stock in a transaction dated Tuesday, January 30th. The shares were sold at an average price of $428.68, for a total value of $7,716,240.00. Following the completion of the transaction, the director now owns 511,410 shares of the company’s stock, valued at $219,231,238.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Mark J. Rubash sold 1,000 shares of the stock in a transaction dated Monday, March 5th. The stock was sold at an average price of $420.01, for a total transaction of $420,010.00. Following the completion of the transaction, the director now directly owns 4,453 shares of the company’s stock, valued at approximately $1,870,304.53. The disclosure for this sale can be found here. Insiders sold 102,770 shares of company stock valued at $43,410,836 in the last three months. Company insiders own 2.20% of the company’s stock.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.27 by $0.27. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The firm had revenue of $892.40 million during the quarter, compared to analyst estimates of $866.54 million. During the same quarter in the prior year, the business posted $2.03 earnings per share. The company’s quarterly revenue was up 17.9% compared to the same quarter last year. equities research analysts predict that Intuitive Surgical, Inc. will post 7.85 earnings per share for the current fiscal year.
ISRG has been the subject of a number of research analyst reports. Stifel Nicolaus reissued a “buy” rating and set a $480.00 target price (up previously from $400.00) on shares of Intuitive Surgical in a research report on Thursday, January 25th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $409.00 target price for the company in a research report on Wednesday, January 3rd. Vetr raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $434.75 target price for the company in a research report on Monday, January 8th. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 12th. Finally, Goldman Sachs reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Saturday, November 18th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $408.76.
Intuitive Surgical Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.